Case Study

Hobart Method Goes Global

When babies are born prematurely their lungs have not developed, often leading to respiratory distress and more serious complications. It had been normal practice to pass a breathing tube into the windpipe to assist with breathing and to administer a chemical called surfactant via the breathing tube to open the airway. But nowadays the breathing tube has been replaced with ‘prongs’ which deliver oxygen directly into the babies nostrils. The challenge with the new method is how to administer surfactant with the absence of a breathing tube.

Professor Peter Dargaville, Director of the Neonatal and Paediatric Intensive Care Unit at the Royal Hobart Hospital has benefited from the RHH Research Foundation clinical grant funding in 2011 and 2012 and also a further grant funded by the MyState Foundation in 2012. This early neonate study has been successful in building research capacity for Professor Dargaville’s current NHMRC funded research which is pioneering a new method of administering surfactant to premature babies.

Dubbed the Hobart Method, through Professor Dargaville’s new technique, surfactant is administered using a minimally invasive tube. The goal for this research is that by administering surfactant treatment babies will not require full ventilation or experience any other complications.
Global trials are now being conducted in over 50 centres worldwide.

The hope for the future is that the Hobart Method will become part of standard care of infants worldwide. Incredible potential for research which, in its infancy, was funded by the RHH Research Foundation.

January 2015


November 7, 2022

This year the Royal Hobart Hospital Research Foundation is proud to be celebrating our 25th anniversary! Over that time, thanks to generous community support, we have invested $10 million across hundreds of local medical research projects. We've highlighted a few of these projects below, showing your support has helped improve countless lives both here in Tasmania and around the world.

November 7, 2022

Millions of Australians have insulin resistance, a silent condition that often has no symptoms. But left untreated it can lead to much more serious diseases like type 2 diabetes, cardiovascular disease, and dementia. We now need your support to raise $25,000 to find out what causes this concerning condition.

September 16, 2022

Tasmania has the highest incidence of Cystic Fibrosis (CF) of any state in Australia, with approximately 110 people with CF.  One of the most dramatic impacts of CF is a dysfunctional immune response – this includes a hyper-inflammatory response that often proves ineffective when faced with ongoing respiratory infections.